第六批高值耗材集采5月落地 临床主流产品“全线”中选

Core Insights - The sixth batch of national high-value medical consumables procurement is set to significantly reduce patient burdens, with the implementation expected by May 2026 [1][3] - A total of 12 types of medical consumables were included, with 496 products from 227 companies bidding, and 440 products from 202 companies selected, achieving an average selection rate of nearly 90% [1][2] Procurement Details - The procurement includes drug-coated balloons and urological intervention consumables, with a market size of approximately 11 billion [1][2] - The clinical demand for these products is high, with annual procurement needs reaching 3.4 million units, covering commonly used clinical varieties [1][2] Selection Process - The selection process was optimized with rules such as anchor pricing, second-round bidding, and revival rules, which effectively increased the selection rate and encouraged companies to bid at reasonable prices [2][3] - The procurement aims to ensure clinical continuity and quality, with a focus on preventing price undercutting and ensuring that products with high clinical recognition and strong supply capabilities are selected [2][3] Product Categories - Drug-coated balloons are used to improve vascular narrowing and are categorized based on the vascular location, while urological consumables are used for stone removal surgeries, covering a wide range of products previously absent in procurement [2][3] - The procurement encompasses all types of products used in urological surgeries, ensuring that patients have access to necessary consumables regardless of the surgical method chosen [2][3]